Xeris Biopharma to Announce Q2 2024 Financial Results on August 8

Xeris Biopharma Holdings, Inc. (Nasdaq: XERS), a biopharmaceutical company focused on growth and innovation, has announced plans to release its financial results for the second quarter of 2023. The results will be available before the U.S. financial markets open on Thursday, August 8, 2024. On the same day, the company’s management will hold a conference call and webcast at 8:30 a.m. Eastern Time to discuss their financial and operational performance.

Interested parties can pre-register for the conference call through a designated link. Upon registration, participants will receive a confirmation email containing the necessary dial-in details and a unique entry code. It is recommended to register at least ten minutes before the call begins. For those unable to attend the live conference call, a replay will be accessible until August 22, 2024, through various contact numbers provided for different regions, including the U.S., UK, and Canada. Additionally, the webcast can be joined via the "Events" section of the investor relations page on the company’s website.

Xeris Biopharma Holdings, Inc. is dedicated to enhancing patient lives by developing and commercializing unique and innovative products. The company markets three key products: Gvoke®, a liquid glucagon for severe hypoglycemia; Keveyis®, a therapy for primary periodic paralysis; and Recorlev®, used in treating endogenous Cushing’s syndrome. In addition to its marketed products, Xeris has a diverse pipeline of developmental and partnered programs utilizing its proprietary formulation technologies, XeriSol™ and XeriJect®. These technologies are designed to ensure long-term product development and commercial success.

Headquartered in Chicago, Illinois, Xeris Biopharma Holdings continues to expand its portfolio with a focus on innovative therapies that address unmet medical needs. 

How to obtain the latest research advancements in the field of biopharmaceuticals?

In the Synapse database, you can keep abreast of the latest research and development advances in drugs, targets, indications, organizations, etc., anywhere and anytime, on a daily or weekly basis. Click on the image below to embark on a brand new journey of drug discovery!